0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Article |

Nipple-Sparing Mastectomy:  Technique and Results of 54 Procedures FREE

Joseph P. Crowe, Jr, MD; Julian A. Kim, MD; Randall Yetman, MD; Jillian Banbury, MD; Rebecca J. Patrick, MA; Deborah Baynes, PA-C
[+] Author Affiliations

From the Departments of General Surgery (Drs Crowe and Kim and Mss Patrick and Baynes) and Plastic Surgery (Drs Yetman and Banbury), The Cleveland Clinic Breast Center, The Cleveland Clinic Foundation, Cleveland, Ohio.


Arch Surg. 2004;139(2):148-150. doi:10.1001/archsurg.139.2.148.
Text Size: A A A
Published online

Hypothesis  The rationale for removal of the nipple-areolar complex (NAC) during total mastectomy centers on long-standing concerns about possible neoplastic involvement of the NAC and its postoperative viability. Nipple-sparing mastectomy (NSM) combines a skin-sparing mastectomy with preservation of the NAC, intraoperative pathological assessment of the nipple tissue core, and immediate reconstruction, thereby permitting better cosmesis for patients undergoing total mastectomy. Neoplastic involvement of the NAC can be predicted before surgery and assessed during the operation, and sustained postoperative viability of the NAC is likely with appropriate surgical technique.

Results  Fifty-four NSMs with immediate reconstruction were attempted among 44 patients. Six NAC core specimens revealed neoplastic involvement on frozen section analysis, resulting in conversion to total mastectomies. Forty-five of the 48 completed NSMs maintained postoperative viability of the NAC; 3 NACs had partial loss.

Conclusion  Nipple-sparing mastectomy is a reasonable option for carefully screened patients.

Figures in this Article

Total mastectomy, as practiced today, discourages preservation of the nipple-areolar complex (NAC) because surgeons have had long-standing concerns about possible neoplastic involvement and postoperative viability of the NAC. Previously published studies18 that considered neoplastic involvement of the NAC often involved retrospective pathological analysis of preserved mastectomy specimens. Reported rates of neoplastic involvement of the NAC varied from 0%7 to 58%.8 Furthermore, some studies adjusted for the likelihood of NAC involvement after correlation with additional possible predictive indicators, including node status,3,4,6,913 tumor size and location within the breast,15,7,917 nuclear grade,25,10,13,15,18 and multicentricity or multifocality.3,5,8,9,13,16 Although most of these studies agreed that neoplastic involvement of the NAC was more likely when tumors were centrally located or greater than 2 to 3 cm in diameter, relative findings were inconsistent and, therefore, prohibitive to a definitive consensus. However, with the success of skin-sparing mastectomy,1821 it became possible to consider nipple-sparing mastectomy (NSM), skin-sparing mastectomy combined with preservation of the NAC, and immediate reconstruction. The purpose of this study was to develop and describe an experience with NSM, with particular attention to neoplastic assessment of the NAC, surgical technique, and sustained postoperative NAC viability.

Data were collected prospectively for 54 consecutive NSM procedures performed between September 5, 2001, and June 11, 2003. All NSM procedures were performed by surgical oncologists (J.P.C. and J.A.K.) and plastic surgeons (R.Y. and J.B.). Nipple-sparing mastectomy was converted to traditional mastectomy if frozen section analysis of the NAC core revealed infiltrating breast cancer or ductal carcinoma in situ (DCIS). Nipple-areolar complex viability was assessed by clinical examination throughout the postoperative course; the minimum postoperative follow-up was 6 weeks.

PATIENT SELECTION

Candidacy for NSM was assessed before and during surgery. Preoperative screening criteria for all patients, whether considering NSM for breast cancer treatment or prophylaxis, included clinical breast examination, thorough review of mammograms, and patient informed consent. For patients with breast cancer, additional preoperative assessment included tumor size and location; patients whose tumors measured greater than 3.5 cm or whose tumors were centrally located were not candidates for NSM. Furthermore, patients who had previously undergone neoadjuvant chemotherapy, had inflammatory breast cancer, or had Paget disease of the nipple were not candidates. Suitability for reconstruction was determined by the plastic surgeon. Intraoperative evaluation included frozen section analysis of the nipple core for 51 of 54 NSM candidates.

SURGICAL TECHNIQUE

Incisions were planned before surgery by the surgical oncologist and plastic surgeon. For those patients undergoing NSM for prophylaxis, mastectomies were performed through an obliquely oriented incision in the upper outer quadrant. For those patients undergoing NSM for breast cancer treatment, diagnosis had been made previously by fine-needle aspiration, core needle biopsy, or surgical excisional biopsy. Nipple-sparing mastectomies in which the preoperative diagnosis had been made by core biopsy were also performed through an upper outer quadrant incision, if possible, thereby allowing axillary access; if the prior biopsy tract was identifiable, it was elliptically excised. Nipple-sparing mastectomy in which the preoperative diagnosis had been made by excisional biopsy incorporated the biopsy incision into the NSM incision.22 Of 48 completed NSMs, 45 were performed through a lateral incision. The remaining 3 cases were performed through a medial incision.

To ensure complete removal of the tissue beneath the NAC, the nipple was everted to facilitate dissection, and the tissue core within the nipple was removed (Figure 1) and sent for frozen section analysis. The NAC was resected if there was evidence of neoplastic involvement on frozen section analysis. Otherwise, viability of the NAC was monitored throughout the operation by visual inspection and capillary refill.

Place holder to copy figure label and caption
Figure 1.

The core of tissue beneath the nipple is removed.

Graphic Jump Location

Fifty-four NSMs were attempted on 44 patients aged 29 to 72 years (mean age, 43 years). Thirty procedures (56%) were performed for infiltrating breast cancer involving tumors measuring 0.1 to 3.5 cm (mean, 1.1 cm); 7 NSMs (13%) were for DCIS; and 17 NSMs (31%) were for prophylaxis. Intraoperative frozen section analysis of the NAC core was performed on 51 of 54 NSMs; cancer was identified in 6 (12%) of 51 specimens. Ductal carcinoma in situ was identified in 5 NAC core analyses, and these breast specimens showed 1 patient with multifocal DCIS, a second patient with multifocal DCIS and a separate 0.3-cm infiltrating ductal carcinoma, a third patient with multiple foci of infiltrating ductal carcinoma and DCIS, and a fourth and a fifth patient with DCIS with a less than 0.1-cm focus of infiltrating ductal carcinoma. A sixth patient had a 2.6-cm infiltrating ductal carcinoma with infiltrating breast cancer identified in the NAC core. None of the NSMs performed for prophylaxis revealed neoplastic involvement of the NAC. Of 37 NSMs performed for breast cancer, 6 (16%) had neoplastic involvement of the NAC, including 1 (14%) of 7 patients with DCIS and 5 (17%) of 30 patients with infiltrating breast cancer.

Although superficial tissue loss of the NAC was common during the first 7 to 21 postoperative days, the 45 completed NSMs performed through a lateral incision are completely intact and well healed, with good cosmesis (Figure 2).

Place holder to copy figure label and caption
Figure 2.

Four months after nipple-sparing mastectomy with implant reconstruction.

Graphic Jump Location

Each of the 3 NSMs that resulted in partial loss of the NAC was performed early in our experience in patients with infiltrating breast cancer. One patient had been diagnosed as having DCIS after ultrasound-guided core biopsy. A subsequent partial mastectomy performed through a medial incision revealed multifocal infiltrating breast cancer with positive margins, resulting in an attempted NSM through the previous medial incision. A second patient had been diagnosed as having infiltrating ductal carcinoma after ultrasound-guided core biopsy for a tumor located medially near the inframammary fold. Infiltrating ductal carcinoma for a third patient had been diagnosed by fine-needle aspiration. The tumor was located close to the skin in the lower outer quadrant, requiring the NSM to be performed through a large wedge resection encompassing most of the skin of the lower outer quadrant and a portion of the lower inner quadrant from the areolar edge to the inframammary fold.

Of 48 completed NSMs, 16 (33%) had transverse rectus abdominis myocutaneous flap reconstructions and 32 (67%) had tissue expander implants placed.

Traditionally, total mastectomy has included removal of the NAC, but because breast cancer screening initiatives have resulted in the detection of smaller tumors, surgeons often need to remove less skin. From this realization evolved the development of the skin-sparing mastectomy combined with immediate reconstruction, thereby permitting enhanced cosmesis.19,20 As skin-sparing mastectomy techniques continue to improve, surgeons are questioning if routine removal of the NAC is necessary for all patients.

The idea of nipple preservation has been reported in the literature for at least 25 years.6 Recent studies have reported that neoplastic involvement of the NAC is rare in patients who have small peripherally located tumors11,14,19 and that long-term viability of the preserved NAC is possible.2326 Nevertheless, little consideration has been given to the fundamental factors that may permit successful clinical application of NSM, including patient selection, neoplastic assessment of the NAC before and during surgery, and analysis of surgical technique to ensure postoperative viability of the NAC.

Our early experience suggests that NSM is an option for carefully screened patients. Those patients whose tumors are peripherally located and 3.5 cm or smaller may be candidates if the nipple is without clinical evidence of disease and the plastic surgeon determines that the breast mound can be adequately reconstructed. Intraoperative frozen section analysis of the nipple core tissue should be performed to assess neoplastic involvement, and, if cancer is identified, the NAC must be resected. Finally, lateral incisions may contribute to the likelihood of sustained NAC viability. Among our 48 completed NSM procedures, each of the 45 performed through a lateral incision has a fully intact and well-healed NAC. Each of the 3 performed through more medially located incisions had partial postoperative NAC loss, possibly suggesting that medial incisions may compromise blood flow. The success of NSM may be based on conscientious preoperative patient selection, multidisciplinary collaboration, pathological analysis of the NAC core, and attention to NSM incision placement.

Corresponding author and reprints: Joseph P. Crowe, Jr, MD, Department of General Surgery, The Cleveland Clinic Breast Center, The Cleveland Clinic Foundation, 9500 Euclid Ave, Desk A80, Cleveland, OH 44195 (e-mail: crowej@ccf.org)

Accepted for publication July 26, 2003.

Luttges  JKalbfleisch  HPrinz  P Nipple involvement and multicentricity in breast cancer: a study on whole organ sections. J Cancer Res Clin Oncol. 1987;113481- 487
PubMed Link to Article
Simmons  RMBrennan  MChristos  PKing  VOsborne  M Analysis of nipple/areolar involvement with mastectomy: can the areola be preserved? Ann Surg Oncol. 2002;9165- 168
PubMed Link to Article
Smith  JPayne  WSCarney  JA Involvement of the nipple and areola in carcinoma of the breast. Surg Gynecol Obstet. 1976;143546- 548
PubMed
Santini  DTaffurelli  MGelli  MC  et al.  Neoplastic involvement of nipple-areolar complex in invasive breast cancer. Am J Surg. 1989;158399- 403
PubMed Link to Article
Morimoto  TKomaki  KInui  K  et al.  Involvement of nipple and areola in early breast cancer. Cancer. 1985;552459- 2463
PubMed Link to Article
Parry  RGCochran  TCWolfort  FG When is there nipple involvement in carcinoma of the breast? Plast Reconstr Surg. 1977;59535- 537
PubMed Link to Article
Verma  GRKumar  AJoshi  K Nipple involvement in peripheral breast carcinoma: a prospective study. Indian J Cancer. 1997;341- 5
PubMed
Menon  RSvan Geel  AN Cancer of the breast with nipple involvement. Br J Cancer. 1989;5981- 84
PubMed Link to Article
Cucin  RLGuthrie  RHLuterman  AGray  GGoulian  D Screening the nipple for involvement in breast cancer. Ann Plast Surg. 1980;5477- 479
PubMed Link to Article
Lambert  PAKolm  PPerry  RR Parameters that predict nipple involvement in breast cancer. J Am Coll Surg. 2000;191354- 359
PubMed Link to Article
Kissin  MWKark  AE Nipple preservation during mastectomy. Br J Surg. 1987;7458- 61
PubMed Link to Article
Wertheim  UOzzello  L Neoplastic involvement of nipple and skin flap in carcinoma of the breast. Am J Surg Pathol. 1980;4543- 549
PubMed Link to Article
Lagios  MDGates  EAWestdahl  PRRichards  VAlpert  B A guide to the frequency of nipple involvement in breast cancer. Am J Surg. 1979;138135- 142
PubMed Link to Article
Vyas  JJChinoy  RFVaidya  JS Prediction of nipple and areola involvement in breast cancer. Eur J Surg Oncol. 1998;2415- 16
PubMed Link to Article
Quinn  RHBarlow  JF Involvement of the nipple and areola by carcinoma of the breast. Arch Surg. 1981;1161139- 1140
PubMed Link to Article
Andersen  JAGram  JBPallesen  RM Involvement of the nipple and areola in breast cancer. Scand J Plast Reconstr Surg. 1981;1539- 42
PubMed Link to Article
Andersen  JAPallesen  RM Spread to the nipple and areola in carcinoma of the breast. Ann Surg. 1979;189367- 372
PubMed Link to Article
Laronga  CKemp  BJohnston  DRobb  GLSingletary  SE The incidence of occult nipple-areola complex involvement in breast cancer patients receiving a skin-sparing mastectomy. Ann Surg Oncol. 1999;6609- 613
PubMed Link to Article
Singletary  SE Skin-sparing mastectomy with immediate breast reconstruction: the M.D. Anderson Cancer Center experience. Ann Surg Oncol. 1996;3411- 416
PubMed Link to Article
Singletary  SE Skin-sparing mastectomy with immediate breast reconstruction. Adv Surg. 1996;3039- 52
PubMed
Carlson  GWBostwick  JStyblo  TM  et al.  Skin-sparing mastectomy: oncologic and reconstructive considerations. Ann Surg. 1997;225570- 578
PubMed Link to Article
Crowe  JPYetman  RBaynes  DPatrick  RTribout  FHentsler  B Nipple-Sparing Mastectomy [movie on CD-ROM].  Cleveland, Ohio Cleveland Clinic Foundation2002;
Jensen  JA When can the nipple-areola complex safely be spared during mastectomy? Plast Reconstr Surg. 2002;109805- 807
PubMed Link to Article
Sufi  PAGittos  MCollier  DS Envelope mastectomy with immediate reconstruction (EMIR). Eur J Surg Oncol. 2000;26367- 370
PubMed Link to Article
Bishop  CCRSingh  SNash  AG Mastectomy and breast reconstruction preserving the nipple. Ann R Coll Surg Engl. 1990;7287- 89
PubMed
Crowe  JPYetman  RJKim  JABanbury  JBarad'l  HBaynes  D Nipple-sparing mastectomy: an alternative to breast conservation?  Poster presented at: 25th Annual San Antonio Breast Cancer Symposium December 12, 2002 San Antonio, Tex. Poster348

Figures

Place holder to copy figure label and caption
Figure 1.

The core of tissue beneath the nipple is removed.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Four months after nipple-sparing mastectomy with implant reconstruction.

Graphic Jump Location

Tables

References

Luttges  JKalbfleisch  HPrinz  P Nipple involvement and multicentricity in breast cancer: a study on whole organ sections. J Cancer Res Clin Oncol. 1987;113481- 487
PubMed Link to Article
Simmons  RMBrennan  MChristos  PKing  VOsborne  M Analysis of nipple/areolar involvement with mastectomy: can the areola be preserved? Ann Surg Oncol. 2002;9165- 168
PubMed Link to Article
Smith  JPayne  WSCarney  JA Involvement of the nipple and areola in carcinoma of the breast. Surg Gynecol Obstet. 1976;143546- 548
PubMed
Santini  DTaffurelli  MGelli  MC  et al.  Neoplastic involvement of nipple-areolar complex in invasive breast cancer. Am J Surg. 1989;158399- 403
PubMed Link to Article
Morimoto  TKomaki  KInui  K  et al.  Involvement of nipple and areola in early breast cancer. Cancer. 1985;552459- 2463
PubMed Link to Article
Parry  RGCochran  TCWolfort  FG When is there nipple involvement in carcinoma of the breast? Plast Reconstr Surg. 1977;59535- 537
PubMed Link to Article
Verma  GRKumar  AJoshi  K Nipple involvement in peripheral breast carcinoma: a prospective study. Indian J Cancer. 1997;341- 5
PubMed
Menon  RSvan Geel  AN Cancer of the breast with nipple involvement. Br J Cancer. 1989;5981- 84
PubMed Link to Article
Cucin  RLGuthrie  RHLuterman  AGray  GGoulian  D Screening the nipple for involvement in breast cancer. Ann Plast Surg. 1980;5477- 479
PubMed Link to Article
Lambert  PAKolm  PPerry  RR Parameters that predict nipple involvement in breast cancer. J Am Coll Surg. 2000;191354- 359
PubMed Link to Article
Kissin  MWKark  AE Nipple preservation during mastectomy. Br J Surg. 1987;7458- 61
PubMed Link to Article
Wertheim  UOzzello  L Neoplastic involvement of nipple and skin flap in carcinoma of the breast. Am J Surg Pathol. 1980;4543- 549
PubMed Link to Article
Lagios  MDGates  EAWestdahl  PRRichards  VAlpert  B A guide to the frequency of nipple involvement in breast cancer. Am J Surg. 1979;138135- 142
PubMed Link to Article
Vyas  JJChinoy  RFVaidya  JS Prediction of nipple and areola involvement in breast cancer. Eur J Surg Oncol. 1998;2415- 16
PubMed Link to Article
Quinn  RHBarlow  JF Involvement of the nipple and areola by carcinoma of the breast. Arch Surg. 1981;1161139- 1140
PubMed Link to Article
Andersen  JAGram  JBPallesen  RM Involvement of the nipple and areola in breast cancer. Scand J Plast Reconstr Surg. 1981;1539- 42
PubMed Link to Article
Andersen  JAPallesen  RM Spread to the nipple and areola in carcinoma of the breast. Ann Surg. 1979;189367- 372
PubMed Link to Article
Laronga  CKemp  BJohnston  DRobb  GLSingletary  SE The incidence of occult nipple-areola complex involvement in breast cancer patients receiving a skin-sparing mastectomy. Ann Surg Oncol. 1999;6609- 613
PubMed Link to Article
Singletary  SE Skin-sparing mastectomy with immediate breast reconstruction: the M.D. Anderson Cancer Center experience. Ann Surg Oncol. 1996;3411- 416
PubMed Link to Article
Singletary  SE Skin-sparing mastectomy with immediate breast reconstruction. Adv Surg. 1996;3039- 52
PubMed
Carlson  GWBostwick  JStyblo  TM  et al.  Skin-sparing mastectomy: oncologic and reconstructive considerations. Ann Surg. 1997;225570- 578
PubMed Link to Article
Crowe  JPYetman  RBaynes  DPatrick  RTribout  FHentsler  B Nipple-Sparing Mastectomy [movie on CD-ROM].  Cleveland, Ohio Cleveland Clinic Foundation2002;
Jensen  JA When can the nipple-areola complex safely be spared during mastectomy? Plast Reconstr Surg. 2002;109805- 807
PubMed Link to Article
Sufi  PAGittos  MCollier  DS Envelope mastectomy with immediate reconstruction (EMIR). Eur J Surg Oncol. 2000;26367- 370
PubMed Link to Article
Bishop  CCRSingh  SNash  AG Mastectomy and breast reconstruction preserving the nipple. Ann R Coll Surg Engl. 1990;7287- 89
PubMed
Crowe  JPYetman  RJKim  JABanbury  JBarad'l  HBaynes  D Nipple-sparing mastectomy: an alternative to breast conservation?  Poster presented at: 25th Annual San Antonio Breast Cancer Symposium December 12, 2002 San Antonio, Tex. Poster348

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 99

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles